Technical Chemicals and Products Inc files for US clearance of cholesterol test:
This article was originally published in Clinica
Technical Chemicals and Products (TCPI) has submitted its total cholesterol home test, HealthCheck, for clearance in the US. The screening test, which will be sold over-the-counter, comprises a test strip that changes colour, which the patient compares with a standardised colour chart. The Pompano Beach, Florida-based company withdrew an earlier test for total cholesterol when the FDA found it had been allowing TCPI to sell the test for home use without formal approval (see Clinica No 798, p 11).
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.